<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Some azole antifungal agents induce <z:hpo ids='HP_0001657'>long QT syndrome</z:hpo> and <z:hpo ids='HP_0011675'>arrhythmias</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Although composite functions of ion channels in cardiomyocytes contribute to the shaping of action potentials, information on the effects of azole antifungal agents on ion currents, except human-<z:chebi fb="91" ids="25698">ether</z:chebi>-a-go-go-related gene (HERG) K+ currents, is largely lacking </plain></SENT>
<SENT sid="2" pm="."><plain>Using the whole cell patch-clamp technique, we investigated the effects of four azole agents (<z:chebi fb="0" ids="6923">miconazole</z:chebi>, <z:chebi fb="0" ids="48339">ketoconazole</z:chebi>, <z:chebi fb="2" ids="46081">fluconazole</z:chebi>, and <z:chebi fb="0" ids="6076">itraconazole</z:chebi>) on inward rectifying K+ currents (IKir), voltage-gated L-type <z:chebi fb="0" ids="29108">Ca2+</z:chebi> currents (ICaL), and delayed rectifier K+ currents (IKdr) in rat neonate ventricular myocytes </plain></SENT>
<SENT sid="3" pm="."><plain>Strikingly, <z:chebi fb="0" ids="6923">miconazole</z:chebi> and <z:chebi fb="0" ids="48339">ketoconazole</z:chebi> strongly inhibited IKir, IKdr, and ICaL at clinically relevant concentrations </plain></SENT>
<SENT sid="4" pm="."><plain>The IC50 values of <z:chebi fb="0" ids="6923">miconazole</z:chebi> for IKdr, IKir, and ICaL inhibition were 2.5, 10.4, and 3.0 µM, respectively </plain></SENT>
<SENT sid="5" pm="."><plain>The IC50 values of <z:chebi fb="0" ids="48339">ketoconazole</z:chebi> for IKdr, IKir and ICaL inhibition were 3.2, 20.8, and 3.5 µM, respectively </plain></SENT>
<SENT sid="6" pm="."><plain><z:chebi fb="2" ids="46081">Fluconazole</z:chebi> and <z:chebi fb="0" ids="6076">itraconazole</z:chebi> had relatively little effect on ion currents </plain></SENT>
<SENT sid="7" pm="."><plain>These findings indicate that <z:chebi fb="0" ids="6923">miconazole</z:chebi> and <z:chebi fb="0" ids="48339">ketoconazole</z:chebi> are multiple ion channel inhibitors in cardiomyocytes </plain></SENT>
<SENT sid="8" pm="."><plain>We suggest that it is necessary to consider this inhibition of ion channels by azole agents when assessing cardiovascular side effects </plain></SENT>
</text></document>